samedan logo
 
 
 
spacer
home > ebr > winter 2001 > a history of proteomics and bioinformatics - in conversation with professor denis hochstrasser
PUBLICATIONS
European Biopharmaceutical Review

A History of Proteomics and Bioinformatics - In Conversation with Professor Denis Hochstrasser

Talking to Denis Hochstrasser about his academic career is a bit like listening to a history lesson in both bioinformatics and proteomics. This is perfect as far as I am concerned since these are two of the sexiest topics in the biotech world today, even though it is obvious that both have been around for quite some time, albeit without the glory that recent innovation has provided. So how did such disciplines evolve? Hearing how Denis moved into computer science and imaging whilst all the time continuing to practice medicine gives a clear insight into how much of today's biotechnology industry, whether in the US or Europe, grew up from core academic research and people 'having ideas'.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Editor of EBR

Denis F. Hochstrasser, MD, is Head of the Central Clinical Chemistry Laboratory at Geneva University Hospital, a Founder of GeneProt, Inc., and Chairman of its Scientific Advisory Board. He is a practising internist and clinical chemist, overseeing all computing activities at Geneva University's Faculty of Medicine and supervising the institute's scientifically renowned proteomics research group. In addition, Denis serves as a Consultant at the Department of Medicine, Chairman of the Informatic Sciences Board and President of the Medical Computing Committee of the Geneva Medicine Faculty.

Denis is also Co-Founder of Geneva Bioinformatics S.A. (GeneBio) and the Swiss Institute for Bioinformatics. He is a former member of Switzerland's highest scientific advisory board, the National Council for Science, as well as numerous international, national and university bodies including the Administration Board of Geneva University, and the Swiss Clinical Chemistry Society Committee. He received his MD from the University of Geneva Medical School.

spacer
Dr Helen Abbott
spacer
spacer
spacer
Denis F. Hochstrasser
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement